Lipocine
LPCN
LPCN
29 hedge funds and large institutions have $3.73M invested in Lipocine in 2018 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
18% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 11
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Holders
29
Holding in Top 10
–
Calls
$96K
Puts
$7K
Top Buyers
| 1 | +$114K | |
| 2 | +$78.3K | |
| 3 | +$48.3K | |
| 4 |
Renaissance Technologies
New York
|
+$40.5K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$39.8K |
Top Sellers
| 1 | -$296K | |
| 2 | -$131K | |
| 3 | -$61K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$21K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$10.1K |